Good news! Sounds almost to good to be true! 😄
"One hundred and forty million people suffer from glaucoma, a degenerative eye disease that can lead to blindness. It is most prevalent among people aged 60 and up.
Glaucoma is generally preventable, either by eye drops or laser surgery. Patients have poor compliance with drops, and laser surgery is cumbersome, uncomfortable and usually performed only by a specialist.
Israeli startup Belkin Laser has developed an alternative laser treatment that is fast, guided by sophisticated image-processing software, and can be offered by any of the 200,000 general ophthalmologists worldwide – and ultimately by non-physician optometrists. ...
The Belkin Laser Eagle system’s advanced image-processing algorithms determine precisely where to aim the laser beams even if the target isn’t directly visible. A proprietary eye tracker allows for easy automation of the treatment, called DSLT – direct selective laser trabeculoplasty. ...
Belkin Laser is named after its founder, Prof. Michael Belkin, an ophthalmologist and serial entrepreneur who initially approached the Rad BioMed accelerator with his idea."
Belkin Laser’s approach to the glaucoma laser procedure is automatic, without contact, by transmitting the laser beam to the TM through the sclera – the white part of the eye. The 100-plus laser beams can be delivered almost simultaneously in seconds.
Belkin Laser is named after its founder, Prof. Michael Belkin, an ophthalmologist and serial entrepreneur who initially approached the Rad BioMed accelerator with his idea."
Belkin Laser CEO Daria Lemann-Blumenthal. More glaucoma patients probably will remember her bright smile in the future
No comments:
Post a Comment